data_1nm4_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1nm4 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . 0.415 ' CB ' ' CD ' ' A' ' 2' ' ' PRO . 61.9 m-70 . . . . . 0 N--CA 1.477 0.898 0 CA-C-O 117.127 -1.416 . . . . 0.0 109.173 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.415 ' CD ' ' CB ' ' A' ' 1' ' ' HIS . 45.2 Cg_endo -75.49 -171.96 1.17 Allowed 'Trans proline' 0 N--CA 1.454 -0.84 0 CA-C-N 121.773 1.669 . . . . 0.0 108.06 160.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 62.63 -163.62 0.26 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.126 0.971 . . . . 0.0 110.013 178.125 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -53.21 122.52 9.66 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.354 1.462 . . . . 0.0 109.608 179.555 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 72.1 t -112.23 -43.39 4.7 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.151 0 C-N-CA 122.928 0.491 . . . . 0.0 110.26 177.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.8 m -136.21 153.67 51.16 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -179.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.3 p -154.24 156.45 37.08 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 174.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 42.2 m -126.45 80.28 69.65 Favored Pre-proline 0 C--N 1.327 -0.399 0 N-CA-C 105.147 -2.168 . . . . 0.0 105.147 158.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -88.19 -79.03 0.0 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.768 0 C-N-CA 122.657 2.238 . . . . 0.0 106.436 -178.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 175.45 43.08 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.053 1.741 . . . . 0.0 110.239 172.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -50.56 96.67 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 119.169 0.895 . . . . 0.0 113.103 -170.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 55.58 29.0 53.02 Favored Glycine 0 CA--C 1.53 1.024 0 CA-C-O 119.513 -0.604 . . . . 0.0 112.66 -177.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 46.8 m -61.75 137.73 58.27 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 118.425 1.113 . . . . 0.0 108.765 173.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -124.17 158.24 32.85 Favored 'General case' 0 N--CA 1.457 -0.11 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 170.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 103.65 -129.64 9.94 Favored Glycine 0 CA--C 1.522 0.519 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 174.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.27 146.18 48.79 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 117.556 0.678 . . . . 0.0 110.107 178.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.05 144.34 69.26 Favored Pre-proline 0 CA--C 1.535 0.397 0 C-N-CA 122.622 0.369 . . . . 0.0 111.252 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -65.31 139.11 58.47 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 122.058 1.839 . . . . 0.0 109.329 174.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.27 -51.09 67.58 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.359 0.6 . . . . 0.0 110.915 -173.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 47.7 pttt -158.3 174.02 15.79 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 126.344 1.858 . . . . 0.0 106.06 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 3.8 mt -119.94 114.38 43.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 124.579 1.152 . . . . 0.0 108.595 179.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -109.19 134.1 52.17 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.826 1.65 . . . . 0.0 109.775 -178.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 15.1 mt -130.6 123.16 28.87 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.112 1.365 . . . . 0.0 110.0 177.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 26.6 m170 -126.94 123.94 38.33 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 125.82 1.648 . . . . 0.0 111.44 -174.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -117.23 138.38 51.74 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 -173.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.7 m -57.76 -46.17 84.89 Favored 'General case' 0 C--N 1.335 -0.044 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 171.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -79.02 137.72 37.69 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.08 -172.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -80.45 81.57 6.68 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 170.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -94.79 -152.86 0.37 Allowed 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 173.26 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 22.8 t 81.88 59.38 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 126.634 1.974 . . . . 0.0 110.318 176.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -82.9 43.18 0.83 Allowed 'General case' 0 CA--C 1.546 0.805 0 CA-C-O 121.915 0.864 . . . . 0.0 111.092 -177.38 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 7.6 tp60 70.64 30.05 3.15 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 120.845 -1.159 . . . . 0.0 113.11 -179.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -144.76 35.72 1.15 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.511 0.725 . . . . 0.0 111.291 178.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.4 m -119.87 156.2 31.18 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 176.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -179.29 177.25 48.28 Favored Glycine 0 CA--C 1.521 0.423 0 N-CA-C 109.009 -1.636 . . . . 0.0 109.009 178.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -156.48 155.13 31.49 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 178.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 79.6 mttt -145.51 168.2 21.17 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.444 1.098 . . . . 0.0 109.003 175.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 53.7 tp -120.54 142.21 49.55 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 17.4 m -131.19 144.88 36.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 104.354 -2.462 . . . . 0.0 104.354 175.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 7.3 ptt? -91.09 135.78 33.53 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 171.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 12.0 t -122.06 -1.39 9.31 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.921 0.888 . . . . 0.0 112.704 -177.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -156.45 132.64 9.89 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 105.281 -2.118 . . . . 0.0 105.281 160.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -148.13 158.32 41.75 Favored Pre-proline 0 C--O 1.236 0.347 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 173.374 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -67.53 170.53 13.5 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 123.115 2.543 . . . . 0.0 110.704 -173.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.46 -52.95 3.52 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 179.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 1.5 mmt -102.6 -58.42 1.88 Allowed 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -166.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 87.5 mt-10 46.45 35.42 2.84 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.929 0.871 . . . . 0.0 111.78 -156.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -74.76 163.27 27.86 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 173.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 5.4 m -46.05 148.79 1.38 Allowed Pre-proline 0 CA--C 1.536 0.435 0 C-N-CA 125.388 1.475 . . . . 0.0 112.316 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -55.83 143.58 80.65 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 123.035 2.49 . . . . 0.0 111.496 -175.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -150.2 149.87 30.8 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 110.305 -0.257 . . . . 0.0 110.305 -169.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.6 131.09 46.01 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.508 0.723 . . . . 0.0 111.468 -172.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -113.27 164.39 9.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-O 121.404 0.621 . . . . 0.0 110.766 -179.157 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -80.68 102.95 10.2 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.727 0.811 . . . . 0.0 111.417 -174.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -126.65 154.76 43.61 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 125.205 1.402 . . . . 0.0 109.304 169.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -115.15 129.42 56.66 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 126.734 2.013 . . . . 0.0 107.974 175.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.1 p -100.16 124.7 53.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 C-N-CA 124.77 1.228 . . . . 0.0 107.864 -178.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.6 m -129.47 178.23 6.62 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 125.846 1.659 . . . . 0.0 108.029 175.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -131.81 164.12 23.68 Favored Glycine 0 CA--C 1.521 0.434 0 N-CA-C 107.704 -2.158 . . . . 0.0 107.704 165.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -73.88 -166.86 14.12 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 109.018 -1.633 . . . . 0.0 109.018 166.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -69.25 5.11 5.45 Favored Glycine 0 CA--C 1.536 1.372 0 O-C-N 121.358 -1.083 . . . . 0.0 114.391 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -122.55 135.05 25.25 Favored Pre-proline 0 N--CA 1.449 -0.504 0 C-N-CA 126.223 1.809 . . . . 0.0 106.143 177.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -62.56 -28.57 77.47 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 122.65 2.233 . . . . 0.0 109.998 176.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 33.5 pttt -81.98 7.55 12.85 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.389 1.076 . . . . 0.0 112.569 179.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 20.8 m -119.78 96.7 5.29 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 178.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 2.7 tpp -89.87 137.72 32.1 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 -177.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 97.4 t -136.3 108.88 8.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 124.191 0.997 . . . . 0.0 109.092 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.0 mp -102.37 125.77 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 C-N-CA 124.798 1.239 . . . . 0.0 107.974 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.41 137.99 19.56 Favored Pre-proline 0 N--CA 1.45 -0.469 0 C-N-CA 125.832 1.653 . . . . 0.0 108.934 173.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -65.97 141.84 66.15 Favored 'Trans proline' 0 N--CA 1.452 -0.965 0 N-CA-C 108.235 -1.487 . . . . 0.0 108.235 160.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -94.24 -30.78 14.4 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 110.448 -0.204 . . . . 0.0 110.448 -179.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -99.04 152.7 37.88 Favored Pre-proline 0 CA--C 1.532 0.255 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 172.223 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -63.96 107.41 0.77 Allowed 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 121.897 1.732 . . . . 0.0 108.644 170.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 82.4 mt -53.64 117.79 3.4 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 124.043 0.937 . . . . 0.0 109.596 176.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.75 173.76 6.17 Favored 'General case' 0 CA--C 1.521 -0.161 0 C-N-CA 124.152 0.981 . . . . 0.0 110.46 177.104 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -48.32 130.56 16.42 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 125.383 1.473 . . . . 0.0 111.303 -172.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 153.01 -161.57 29.67 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 -176.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 27.8 m -128.36 143.12 50.97 Favored 'General case' 0 C--O 1.231 0.109 0 C-N-CA 125.361 1.464 . . . . 0.0 108.616 175.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -136.49 162.92 31.75 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 123.683 0.793 . . . . 0.0 110.064 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 20.4 tttt -127.74 121.42 30.25 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 126.055 1.742 . . . . 0.0 108.823 173.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 20.5 t -82.06 120.35 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 N-CA-C 104.634 -2.358 . . . . 0.0 104.634 163.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -102.3 121.67 42.72 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 106.306 -1.739 . . . . 0.0 106.306 164.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 16.5 p-90 -115.96 146.37 42.15 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 172.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 4.3 mtt180 -133.42 112.26 11.43 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 125.18 1.392 . . . . 0.0 107.774 177.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -109.25 135.46 50.3 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 123.399 0.679 . . . . 0.0 111.982 175.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 36.9 t -129.2 147.48 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 O-C-N 120.82 -1.175 . . . . 0.0 110.931 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 7.4 t -108.19 166.99 10.33 Favored 'General case' 0 C--N 1.34 0.169 0 C-N-CA 124.562 1.145 . . . . 0.0 111.045 178.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 67.7 m -51.82 -55.06 22.21 Favored 'General case' 0 C--N 1.339 0.127 0 C-N-CA 124.005 0.922 . . . . 0.0 109.392 173.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -78.28 45.92 0.58 Allowed 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.612 1.165 . . . . 0.0 110.063 -178.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 30.1 p 57.43 -103.09 0.17 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 126.209 1.804 . . . . 0.0 110.476 -174.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 4.0 t-80 40.42 67.41 2.79 Favored Pre-proline 0 N--CA 1.452 -0.349 0 C-N-CA 127.007 2.123 . . . . 0.0 111.371 178.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -69.26 137.9 38.06 Favored 'Trans proline' 0 N--CA 1.44 -1.675 0 N-CA-C 108.148 -1.52 . . . . 0.0 108.148 177.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 2.6 pt -114.26 123.16 69.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 N-CA-C 104.176 -2.528 . . . . 0.0 104.176 159.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 33.1 p -123.83 134.88 53.52 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 174.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -160.81 171.93 37.02 Favored Glycine 0 N--CA 1.445 -0.757 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 -166.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -154.16 153.51 31.93 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 123.549 0.74 . . . . 0.0 111.929 -175.179 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 56.0 t -133.24 126.84 53.44 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 C-N-CA 126.865 2.066 . . . . 0.0 106.509 177.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -98.47 151.61 20.42 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 118.797 0.726 . . . . 0.0 109.669 172.29 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -150.15 166.31 30.22 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.454 0.702 . . . . 0.0 109.752 173.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 75.3 mttt -121.69 157.23 31.37 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.019 1.728 . . . . 0.0 109.012 177.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 61.4 t -132.55 143.7 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 178.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 71.5 mttt . . . . . 0 C--O 1.249 1.031 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 164.222 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' HIS . . . . . 0.415 ' CB ' ' CD ' ' A' ' 2' ' ' PRO . 61.9 m-70 . . . . . 0 N--CA 1.477 0.898 0 CA-C-O 117.127 -1.416 . . . . 0.0 109.173 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.415 ' CD ' ' CB ' ' A' ' 1' ' ' HIS . 45.2 Cg_endo -75.49 -171.96 1.17 Allowed 'Trans proline' 0 N--CA 1.454 -0.84 0 CA-C-N 121.773 1.669 . . . . 0.0 108.06 160.508 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 62.63 -163.62 0.26 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.126 0.971 . . . . 0.0 110.013 178.125 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -53.21 122.52 9.66 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.354 1.462 . . . . 0.0 109.608 179.555 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.471 HG21 ' OG ' ' A' ' 26' ' ' SER . 72.1 t -112.23 -43.39 4.7 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.151 0 C-N-CA 122.928 0.491 . . . . 0.0 110.26 177.175 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.8 m -136.21 153.67 51.16 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -179.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.3 p -154.24 156.45 37.08 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 174.076 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 42.2 m -126.45 80.28 69.65 Favored Pre-proline 0 C--N 1.327 -0.399 0 N-CA-C 105.147 -2.168 . . . . 0.0 105.147 158.072 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -88.19 -79.03 0.0 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.768 0 C-N-CA 122.657 2.238 . . . . 0.0 106.436 -178.305 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 175.45 43.08 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.053 1.741 . . . . 0.0 110.239 172.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -50.56 96.67 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 119.169 0.895 . . . . 0.0 113.103 -170.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 55.58 29.0 53.02 Favored Glycine 0 CA--C 1.53 1.024 0 CA-C-O 119.513 -0.604 . . . . 0.0 112.66 -177.427 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 46.8 m -61.75 137.73 58.27 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 118.425 1.113 . . . . 0.0 108.765 173.064 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -124.17 158.24 32.85 Favored 'General case' 0 N--CA 1.457 -0.11 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 170.077 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 103.65 -129.64 9.94 Favored Glycine 0 CA--C 1.522 0.519 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 174.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.27 146.18 48.79 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 117.556 0.678 . . . . 0.0 110.107 178.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.05 144.34 69.26 Favored Pre-proline 0 CA--C 1.535 0.397 0 C-N-CA 122.622 0.369 . . . . 0.0 111.252 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -65.31 139.11 58.47 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 122.058 1.839 . . . . 0.0 109.329 174.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.27 -51.09 67.58 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.359 0.6 . . . . 0.0 110.915 -173.019 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 47.7 pttt -158.3 174.02 15.79 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 126.344 1.858 . . . . 0.0 106.06 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 3.8 mt -119.94 114.38 43.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 124.579 1.152 . . . . 0.0 108.595 179.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -109.19 134.1 52.17 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.826 1.65 . . . . 0.0 109.775 -178.144 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 15.1 mt -130.6 123.16 28.87 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.112 1.365 . . . . 0.0 110.0 177.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 26.6 m170 -126.94 123.94 38.33 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 125.82 1.648 . . . . 0.0 111.44 -174.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -117.23 138.38 51.74 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 -173.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.471 ' OG ' HG21 ' A' ' 5' ' ' VAL . 3.7 m -57.76 -46.17 84.89 Favored 'General case' 0 C--N 1.335 -0.044 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 171.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -79.02 137.72 37.69 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.08 -172.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 30.4 t30 -80.45 81.57 6.68 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 170.012 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.608 HD11 ' HB1' ' A' ' 85' ' ' ALA . 0.8 OUTLIER -94.79 -152.86 0.37 Allowed 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 173.26 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.434 HG13 ' HB2' ' A' ' 34' ' ' SER . 22.8 t 81.88 59.38 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 126.634 1.974 . . . . 0.0 110.318 176.023 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.522 HG23 ' O ' ' A' ' 31' ' ' THR . 0.7 OUTLIER -82.9 43.18 0.83 Allowed 'General case' 0 CA--C 1.546 0.805 0 CA-C-O 121.915 0.864 . . . . 0.0 111.092 -177.38 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 7.6 tp60 70.64 30.05 3.15 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 120.845 -1.159 . . . . 0.0 113.11 -179.046 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -144.76 35.72 1.15 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.511 0.725 . . . . 0.0 111.291 178.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.434 ' HB2' HG13 ' A' ' 30' ' ' VAL . 50.4 m -119.87 156.2 31.18 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 176.246 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -179.29 177.25 48.28 Favored Glycine 0 CA--C 1.521 0.423 0 N-CA-C 109.009 -1.636 . . . . 0.0 109.009 178.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -156.48 155.13 31.49 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 178.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 79.6 mttt -145.51 168.2 21.17 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.444 1.098 . . . . 0.0 109.003 175.071 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.404 HD11 ' HB3' ' A' ' 79' ' ' TYR . 53.7 tp -120.54 142.21 49.55 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 -179.392 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.604 HG12 ' HA ' ' A' ' 52' ' ' ALA . 17.4 m -131.19 144.88 36.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 104.354 -2.462 . . . . 0.0 104.354 175.609 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 7.3 ptt? -91.09 135.78 33.53 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 171.089 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 12.0 t -122.06 -1.39 9.31 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.921 0.888 . . . . 0.0 112.704 -177.006 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -156.45 132.64 9.89 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 105.281 -2.118 . . . . 0.0 105.281 160.061 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -148.13 158.32 41.75 Favored Pre-proline 0 C--O 1.236 0.347 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 173.374 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -67.53 170.53 13.5 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 123.115 2.543 . . . . 0.0 110.704 -173.136 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.46 -52.95 3.52 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 179.512 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 1.5 mmt -102.6 -58.42 1.88 Allowed 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -166.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 87.5 mt-10 46.45 35.42 2.84 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.929 0.871 . . . . 0.0 111.78 -156.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -74.76 163.27 27.86 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 173.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 5.4 m -46.05 148.79 1.38 Allowed Pre-proline 0 CA--C 1.536 0.435 0 C-N-CA 125.388 1.475 . . . . 0.0 112.316 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -55.83 143.58 80.65 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 123.035 2.49 . . . . 0.0 111.496 -175.195 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -150.2 149.87 30.8 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 110.305 -0.257 . . . . 0.0 110.305 -169.361 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.604 ' HA ' HG12 ' A' ' 39' ' ' VAL . . . -64.6 131.09 46.01 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.508 0.723 . . . . 0.0 111.468 -172.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -113.27 164.39 9.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-O 121.404 0.621 . . . . 0.0 110.766 -179.157 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -80.68 102.95 10.2 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.727 0.811 . . . . 0.0 111.417 -174.257 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -126.65 154.76 43.61 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 125.205 1.402 . . . . 0.0 109.304 169.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -115.15 129.42 56.66 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 126.734 2.013 . . . . 0.0 107.974 175.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.1 p -100.16 124.7 53.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 C-N-CA 124.77 1.228 . . . . 0.0 107.864 -178.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.6 m -129.47 178.23 6.62 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 125.846 1.659 . . . . 0.0 108.029 175.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -131.81 164.12 23.68 Favored Glycine 0 CA--C 1.521 0.434 0 N-CA-C 107.704 -2.158 . . . . 0.0 107.704 165.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -73.88 -166.86 14.12 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 109.018 -1.633 . . . . 0.0 109.018 166.07 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -69.25 5.11 5.45 Favored Glycine 0 CA--C 1.536 1.372 0 O-C-N 121.358 -1.083 . . . . 0.0 114.391 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -122.55 135.05 25.25 Favored Pre-proline 0 N--CA 1.449 -0.504 0 C-N-CA 126.223 1.809 . . . . 0.0 106.143 177.606 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -62.56 -28.57 77.47 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 122.65 2.233 . . . . 0.0 109.998 176.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 33.5 pttt -81.98 7.55 12.85 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.389 1.076 . . . . 0.0 112.569 179.255 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 20.8 m -119.78 96.7 5.29 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 178.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 2.7 tpp -89.87 137.72 32.1 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 -177.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 97.4 t -136.3 108.88 8.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 124.191 0.997 . . . . 0.0 109.092 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.0 mp -102.37 125.77 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 C-N-CA 124.798 1.239 . . . . 0.0 107.974 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.41 137.99 19.56 Favored Pre-proline 0 N--CA 1.45 -0.469 0 C-N-CA 125.832 1.653 . . . . 0.0 108.934 173.137 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -65.97 141.84 66.15 Favored 'Trans proline' 0 N--CA 1.452 -0.965 0 N-CA-C 108.235 -1.487 . . . . 0.0 108.235 160.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -94.24 -30.78 14.4 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 110.448 -0.204 . . . . 0.0 110.448 -179.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -99.04 152.7 37.88 Favored Pre-proline 0 CA--C 1.532 0.255 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 172.223 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -63.96 107.41 0.77 Allowed 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 121.897 1.732 . . . . 0.0 108.644 170.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 82.4 mt -53.64 117.79 3.4 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 124.043 0.937 . . . . 0.0 109.596 176.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.75 173.76 6.17 Favored 'General case' 0 CA--C 1.521 -0.161 0 C-N-CA 124.152 0.981 . . . . 0.0 110.46 177.104 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -48.32 130.56 16.42 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 125.383 1.473 . . . . 0.0 111.303 -172.238 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 153.01 -161.57 29.67 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 -176.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 27.8 m -128.36 143.12 50.97 Favored 'General case' 0 C--O 1.231 0.109 0 C-N-CA 125.361 1.464 . . . . 0.0 108.616 175.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.404 ' HB3' HD11 ' A' ' 38' ' ' LEU . 33.2 m-85 -136.49 162.92 31.75 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 123.683 0.793 . . . . 0.0 110.064 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 20.4 tttt -127.74 121.42 30.25 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 126.055 1.742 . . . . 0.0 108.823 173.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 20.5 t -82.06 120.35 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 N-CA-C 104.634 -2.358 . . . . 0.0 104.634 163.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -102.3 121.67 42.72 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 106.306 -1.739 . . . . 0.0 106.306 164.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 16.5 p-90 -115.96 146.37 42.15 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 172.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 4.3 mtt180 -133.42 112.26 11.43 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 125.18 1.392 . . . . 0.0 107.774 177.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.608 ' HB1' HD11 ' A' ' 29' ' ' LEU . . . -109.25 135.46 50.3 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 123.399 0.679 . . . . 0.0 111.982 175.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 36.9 t -129.2 147.48 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 O-C-N 120.82 -1.175 . . . . 0.0 110.931 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 7.4 t -108.19 166.99 10.33 Favored 'General case' 0 C--N 1.34 0.169 0 C-N-CA 124.562 1.145 . . . . 0.0 111.045 178.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 67.7 m -51.82 -55.06 22.21 Favored 'General case' 0 C--N 1.339 0.127 0 C-N-CA 124.005 0.922 . . . . 0.0 109.392 173.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -78.28 45.92 0.58 Allowed 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.612 1.165 . . . . 0.0 110.063 -178.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 30.1 p 57.43 -103.09 0.17 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 126.209 1.804 . . . . 0.0 110.476 -174.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 4.0 t-80 40.42 67.41 2.79 Favored Pre-proline 0 N--CA 1.452 -0.349 0 C-N-CA 127.007 2.123 . . . . 0.0 111.371 178.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -69.26 137.9 38.06 Favored 'Trans proline' 0 N--CA 1.44 -1.675 0 N-CA-C 108.148 -1.52 . . . . 0.0 108.148 177.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.498 HG13 ' HB3' ' A' ' 85' ' ' ALA . 2.6 pt -114.26 123.16 69.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 N-CA-C 104.176 -2.528 . . . . 0.0 104.176 159.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 33.1 p -123.83 134.88 53.52 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 174.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -160.81 171.93 37.02 Favored Glycine 0 N--CA 1.445 -0.757 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 -166.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -154.16 153.51 31.93 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 123.549 0.74 . . . . 0.0 111.929 -175.179 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 56.0 t -133.24 126.84 53.44 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 C-N-CA 126.865 2.066 . . . . 0.0 106.509 177.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -98.47 151.61 20.42 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 118.797 0.726 . . . . 0.0 109.669 172.29 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -150.15 166.31 30.22 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.454 0.702 . . . . 0.0 109.752 173.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 75.3 mttt -121.69 157.23 31.37 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.019 1.728 . . . . 0.0 109.012 177.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 61.4 t -132.55 143.7 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 178.124 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 71.5 mttt . . . . . 0 C--O 1.249 1.031 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 164.222 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . 0.415 ' CB ' ' CD ' ' A' ' 2' ' ' PRO . 61.9 m-70 . . . . . 0 N--CA 1.477 0.898 0 CA-C-O 117.127 -1.416 . . . . 0.0 109.173 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.415 ' CD ' ' CB ' ' A' ' 1' ' ' HIS . 45.2 Cg_endo -75.49 -171.96 1.17 Allowed 'Trans proline' 0 N--CA 1.454 -0.84 0 CA-C-N 121.773 1.669 . . . . 0.0 108.06 160.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 62.63 -163.62 0.26 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.126 0.971 . . . . 0.0 110.013 178.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -53.21 122.52 9.66 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.354 1.462 . . . . 0.0 109.608 179.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.471 HG21 ' OG ' ' A' ' 26' ' ' SER . 72.1 t -112.23 -43.39 4.7 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.151 0 C-N-CA 122.928 0.491 . . . . 0.0 110.26 177.175 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.8 m -136.21 153.67 51.16 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -179.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.3 p -154.24 156.45 37.08 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 174.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 42.2 m -126.45 80.28 69.65 Favored Pre-proline 0 C--N 1.327 -0.399 0 N-CA-C 105.147 -2.168 . . . . 0.0 105.147 158.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -88.19 -79.03 0.0 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.768 0 C-N-CA 122.657 2.238 . . . . 0.0 106.436 -178.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 175.45 43.08 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.053 1.741 . . . . 0.0 110.239 172.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -50.56 96.67 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 119.169 0.895 . . . . 0.0 113.103 -170.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 55.58 29.0 53.02 Favored Glycine 0 CA--C 1.53 1.024 0 CA-C-O 119.513 -0.604 . . . . 0.0 112.66 -177.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 46.8 m -61.75 137.73 58.27 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 118.425 1.113 . . . . 0.0 108.765 173.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -124.17 158.24 32.85 Favored 'General case' 0 N--CA 1.457 -0.11 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 170.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 103.65 -129.64 9.94 Favored Glycine 0 CA--C 1.522 0.519 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 174.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.27 146.18 48.79 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 117.556 0.678 . . . . 0.0 110.107 178.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.05 144.34 69.26 Favored Pre-proline 0 CA--C 1.535 0.397 0 C-N-CA 122.622 0.369 . . . . 0.0 111.252 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -65.31 139.11 58.47 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 122.058 1.839 . . . . 0.0 109.329 174.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.27 -51.09 67.58 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.359 0.6 . . . . 0.0 110.915 -173.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 47.7 pttt -158.3 174.02 15.79 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 126.344 1.858 . . . . 0.0 106.06 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 3.8 mt -119.94 114.38 43.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 124.579 1.152 . . . . 0.0 108.595 179.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -109.19 134.1 52.17 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.826 1.65 . . . . 0.0 109.775 -178.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 15.1 mt -130.6 123.16 28.87 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.112 1.365 . . . . 0.0 110.0 177.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 26.6 m170 -126.94 123.94 38.33 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 125.82 1.648 . . . . 0.0 111.44 -174.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -117.23 138.38 51.74 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 -173.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.471 ' OG ' HG21 ' A' ' 5' ' ' VAL . 3.7 m -57.76 -46.17 84.89 Favored 'General case' 0 C--N 1.335 -0.044 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 171.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -79.02 137.72 37.69 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.08 -172.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -80.45 81.57 6.68 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 170.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.608 HD11 ' HB1' ' A' ' 85' ' ' ALA . 0.8 OUTLIER -94.79 -152.86 0.37 Allowed 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 173.26 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.434 HG13 ' HB2' ' A' ' 34' ' ' SER . 22.8 t 81.88 59.38 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 126.634 1.974 . . . . 0.0 110.318 176.023 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.522 HG23 ' O ' ' A' ' 31' ' ' THR . 0.7 OUTLIER -82.9 43.18 0.83 Allowed 'General case' 0 CA--C 1.546 0.805 0 CA-C-O 121.915 0.864 . . . . 0.0 111.092 -177.38 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 7.6 tp60 70.64 30.05 3.15 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 120.845 -1.159 . . . . 0.0 113.11 -179.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -144.76 35.72 1.15 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.511 0.725 . . . . 0.0 111.291 178.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.434 ' HB2' HG13 ' A' ' 30' ' ' VAL . 50.4 m -119.87 156.2 31.18 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 176.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -179.29 177.25 48.28 Favored Glycine 0 CA--C 1.521 0.423 0 N-CA-C 109.009 -1.636 . . . . 0.0 109.009 178.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -156.48 155.13 31.49 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 178.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 79.6 mttt -145.51 168.2 21.17 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.444 1.098 . . . . 0.0 109.003 175.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.404 HD11 ' HB3' ' A' ' 79' ' ' TYR . 53.7 tp -120.54 142.21 49.55 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 -179.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.604 HG12 ' HA ' ' A' ' 52' ' ' ALA . 17.4 m -131.19 144.88 36.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 104.354 -2.462 . . . . 0.0 104.354 175.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 7.3 ptt? -91.09 135.78 33.53 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 171.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 12.0 t -122.06 -1.39 9.31 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.921 0.888 . . . . 0.0 112.704 -177.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -156.45 132.64 9.89 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 105.281 -2.118 . . . . 0.0 105.281 160.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -148.13 158.32 41.75 Favored Pre-proline 0 C--O 1.236 0.347 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 173.374 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -67.53 170.53 13.5 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 123.115 2.543 . . . . 0.0 110.704 -173.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.46 -52.95 3.52 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 179.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 1.5 mmt -102.6 -58.42 1.88 Allowed 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -166.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 87.5 mt-10 46.45 35.42 2.84 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.929 0.871 . . . . 0.0 111.78 -156.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -74.76 163.27 27.86 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 173.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 5.4 m -46.05 148.79 1.38 Allowed Pre-proline 0 CA--C 1.536 0.435 0 C-N-CA 125.388 1.475 . . . . 0.0 112.316 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -55.83 143.58 80.65 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 123.035 2.49 . . . . 0.0 111.496 -175.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -150.2 149.87 30.8 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 110.305 -0.257 . . . . 0.0 110.305 -169.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.604 ' HA ' HG12 ' A' ' 39' ' ' VAL . . . -64.6 131.09 46.01 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.508 0.723 . . . . 0.0 111.468 -172.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -113.27 164.39 9.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-O 121.404 0.621 . . . . 0.0 110.766 -179.157 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -80.68 102.95 10.2 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.727 0.811 . . . . 0.0 111.417 -174.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -126.65 154.76 43.61 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 125.205 1.402 . . . . 0.0 109.304 169.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -115.15 129.42 56.66 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 126.734 2.013 . . . . 0.0 107.974 175.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.1 p -100.16 124.7 53.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 C-N-CA 124.77 1.228 . . . . 0.0 107.864 -178.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.6 m -129.47 178.23 6.62 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 125.846 1.659 . . . . 0.0 108.029 175.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -131.81 164.12 23.68 Favored Glycine 0 CA--C 1.521 0.434 0 N-CA-C 107.704 -2.158 . . . . 0.0 107.704 165.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -73.88 -166.86 14.12 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 109.018 -1.633 . . . . 0.0 109.018 166.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -69.25 5.11 5.45 Favored Glycine 0 CA--C 1.536 1.372 0 O-C-N 121.358 -1.083 . . . . 0.0 114.391 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -122.55 135.05 25.25 Favored Pre-proline 0 N--CA 1.449 -0.504 0 C-N-CA 126.223 1.809 . . . . 0.0 106.143 177.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -62.56 -28.57 77.47 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 122.65 2.233 . . . . 0.0 109.998 176.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 33.5 pttt -81.98 7.55 12.85 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.389 1.076 . . . . 0.0 112.569 179.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 20.8 m -119.78 96.7 5.29 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 178.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 2.7 tpp -89.87 137.72 32.1 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 -177.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 97.4 t -136.3 108.88 8.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 124.191 0.997 . . . . 0.0 109.092 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.0 mp -102.37 125.77 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 C-N-CA 124.798 1.239 . . . . 0.0 107.974 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.41 137.99 19.56 Favored Pre-proline 0 N--CA 1.45 -0.469 0 C-N-CA 125.832 1.653 . . . . 0.0 108.934 173.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -65.97 141.84 66.15 Favored 'Trans proline' 0 N--CA 1.452 -0.965 0 N-CA-C 108.235 -1.487 . . . . 0.0 108.235 160.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -94.24 -30.78 14.4 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 110.448 -0.204 . . . . 0.0 110.448 -179.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -99.04 152.7 37.88 Favored Pre-proline 0 CA--C 1.532 0.255 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 172.223 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -63.96 107.41 0.77 Allowed 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 121.897 1.732 . . . . 0.0 108.644 170.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 82.4 mt -53.64 117.79 3.4 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 124.043 0.937 . . . . 0.0 109.596 176.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.75 173.76 6.17 Favored 'General case' 0 CA--C 1.521 -0.161 0 C-N-CA 124.152 0.981 . . . . 0.0 110.46 177.104 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -48.32 130.56 16.42 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 125.383 1.473 . . . . 0.0 111.303 -172.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 153.01 -161.57 29.67 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 -176.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 27.8 m -128.36 143.12 50.97 Favored 'General case' 0 C--O 1.231 0.109 0 C-N-CA 125.361 1.464 . . . . 0.0 108.616 175.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.404 ' HB3' HD11 ' A' ' 38' ' ' LEU . 33.2 m-85 -136.49 162.92 31.75 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 123.683 0.793 . . . . 0.0 110.064 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 20.4 tttt -127.74 121.42 30.25 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 126.055 1.742 . . . . 0.0 108.823 173.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 20.5 t -82.06 120.35 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 N-CA-C 104.634 -2.358 . . . . 0.0 104.634 163.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -102.3 121.67 42.72 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 106.306 -1.739 . . . . 0.0 106.306 164.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 16.5 p-90 -115.96 146.37 42.15 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 172.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 4.3 mtt180 -133.42 112.26 11.43 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 125.18 1.392 . . . . 0.0 107.774 177.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.608 ' HB1' HD11 ' A' ' 29' ' ' LEU . . . -109.25 135.46 50.3 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 123.399 0.679 . . . . 0.0 111.982 175.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 36.9 t -129.2 147.48 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 O-C-N 120.82 -1.175 . . . . 0.0 110.931 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 7.4 t -108.19 166.99 10.33 Favored 'General case' 0 C--N 1.34 0.169 0 C-N-CA 124.562 1.145 . . . . 0.0 111.045 178.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 67.7 m -51.82 -55.06 22.21 Favored 'General case' 0 C--N 1.339 0.127 0 C-N-CA 124.005 0.922 . . . . 0.0 109.392 173.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -78.28 45.92 0.58 Allowed 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.612 1.165 . . . . 0.0 110.063 -178.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 30.1 p 57.43 -103.09 0.17 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 126.209 1.804 . . . . 0.0 110.476 -174.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 4.0 t-80 40.42 67.41 2.79 Favored Pre-proline 0 N--CA 1.452 -0.349 0 C-N-CA 127.007 2.123 . . . . 0.0 111.371 178.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -69.26 137.9 38.06 Favored 'Trans proline' 0 N--CA 1.44 -1.675 0 N-CA-C 108.148 -1.52 . . . . 0.0 108.148 177.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.498 HG13 ' HB3' ' A' ' 85' ' ' ALA . 2.6 pt -114.26 123.16 69.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 N-CA-C 104.176 -2.528 . . . . 0.0 104.176 159.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 33.1 p -123.83 134.88 53.52 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 174.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -160.81 171.93 37.02 Favored Glycine 0 N--CA 1.445 -0.757 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 -166.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -154.16 153.51 31.93 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 123.549 0.74 . . . . 0.0 111.929 -175.179 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 56.0 t -133.24 126.84 53.44 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 C-N-CA 126.865 2.066 . . . . 0.0 106.509 177.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -98.47 151.61 20.42 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 118.797 0.726 . . . . 0.0 109.669 172.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -150.15 166.31 30.22 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.454 0.702 . . . . 0.0 109.752 173.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 75.3 mttt -121.69 157.23 31.37 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.019 1.728 . . . . 0.0 109.012 177.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 61.4 t -132.55 143.7 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 178.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 71.5 mttt . . . . . 0 C--O 1.249 1.031 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 164.222 . . . . . . . . 0 0 . 1 stop_ save_